Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Verisk Analytics £250 million acquisition of Sequel
Davis Polk is advising Verisk Analytics, Inc. in connection with its £250 million acquisition of Sequel from HgCapital and…
Davis Polk Advises PharMerica on Its Acquisition by KKR and Walgreens
Davis Polk is advising PharMerica Corporation on its approximately $1.4 billion acquisition by a newly formed company…
Sienna Biopharmaceuticals Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 4,983,333 shares of common stock of…
Davis Polk Advises Noble on the Sale of Noble Americas Gas & Power Corp. to Mercuria Energy America
Davis Polk is advising Noble Group Limited on the sale of its wholly-owned subsidiary Noble Americas Gas & Power Corp…
Davis Polk Advises Calyxt, Inc. on Its Initial Public Offering
Davis Polk advised Calyxt, Inc. in connection with its initial public offering of 8,050,000 shares of its common stock,…
Kala Pharmaceuticals, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with the $103.5 million initial public…
Davis Polk Advises Mitsubishi Tanabe Pharma on Its Acquisition of NeuroDerm
Davis Polk is advising Mitsubishi Tanabe Pharma Corporation on its approximately $1.1 billion acquisition of NeuroDerm Ltd…
Akcea Therapeutics Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 17,968,750 shares of common stock of…
Davis Polk Advises Reckitt Benckiser on the Sale of Its Food Division to McCormick
Davis Polk is advising Reckitt Benckiser Group plc on the sale of its Food Division to McCormick & Company Inc. for $4.2…
Mersana Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75…